Growth Hormone Signaling
Studied for its stimulation of endogenous growth hormone secretion via the GHRH receptor.
Overview
Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH), extending the native 44-amino acid sequence with a stabilizing hexenoyl modification at the N-terminus. This structural change confers resistance to enzymatic degradation, making it a durable tool for studying growth hormone secretion and downstream metabolic pathways.
Suria's Tesamorelin is manufactured for high-purity peptide research, with analytical documentation to be made available through Suria's Batch Documentation system, supporting controlled research into GHRH-receptor activation and downstream GH/IGF-1 signaling.
Research Use Only. Not for human or veterinary use.
Specifications
Certificate of Analysis
Certificate of Analysis
Checking certificate…
Other documentation: Batch Documentation.
Research Highlights
Studied for its stimulation of endogenous growth hormone secretion via the GHRH receptor.
Studied as a stabilized GHRH analogue that activates GHRH receptors and downstream GH/IGF-1 signaling.
Engineered with an N-terminal modification that resists rapid enzymatic breakdown.
One of the most extensively studied GHRH analogs in metabolic research.
Storage
Store as specified above, protected from light and moisture, until ready for reconstitution.
Store at 2–8°C and use within the laboratory's established handling window.
Avoid repeated freeze-thaw cycles to help preserve peptide integrity across a research protocol.
Research Use Only. Not for human consumption.
Frequently Asked Questions
Batch Documentation